Inhibition of Endothelial Cell Growth by TNP-470
Author Information
Author(s): M. Kusakal, K. Sudol, E. Matsutani, Y. Kozail, S. Maruil, T. Fujital, D. Ingber, J. Folkman
Primary Institution: Pharmaceutical Research Laboratories III, Pharmaceutical Research Division, Takeda Chemical Industries Ltd.
Hypothesis
Does TNP-470 inhibit the growth of human umbilical vein endothelial cells in a biphasic manner?
Conclusion
TNP-470 inhibits endothelial cell growth in a biphasic manner, with cytostatic effects at lower concentrations and cytotoxic effects at higher concentrations.
Supporting Evidence
- TNP-470 inhibited HUVE cell growth in a biphasic manner.
- The first phase of inhibition was cytostatic, while the second phase was cytotoxic.
- Endothelial cells were the most sensitive to TNP-470.
- Cytostatic inhibition continued even after TNP-470 was removed from the culture.
Takeaway
TNP-470 is a drug that stops certain cells from growing, first by slowing them down and then by killing them if the dose is high enough.
Methodology
The study examined the effects of TNP-470 on HUVE cells using growth inhibition assays and incorporation of thymidine, uridine, and leucine.
Limitations
The study does not specify the long-term effects of TNP-470 on different cell types or its clinical applicability.
Statistical Information
P-Value
15 pg ml-1
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website